Linq Management GmbH

Linq Management GmbH is an SME in Berlin, Germany that has taken part in 12 EU-funded projects since 2019, receiving €4.2M in EU funding.

EU funding received€4.2M
EU projects12
As coordinator0
Running now10
First EU project2019
Latest project2027
CountryGermany
EU registration (PIC)916451054
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Linq Management GmbH's own share of each project, not the project's full budget.

  • Horizon Europe€3.7M · 10 projects
  • Horizon 2020€482k · 2 projects

Projects

12 EU-funded projects, newest first. Each links to the official record.

  • Vax4eUAssociated partner

    Vaccinologists for Europe: Training network for developing next generation vaccines against mucosal pathogens

    Horizon Europe · 2027–2031 · Project on CORDIS ↗

  • REPhRAMEPartner

    REcurrent urinary tract infection: Efficacy and safety of PHage theRapy and Microbiota transfEr

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €578ktheir share
  • PRECISE-TBMPartner

    Prospective evaluation and refinement of novel biomarker-based point-of-care tests for the diagnosis of tuberculous meningitis in children

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

    €387ktheir share
  • AddiCADPartner

    FIELD TESTING OF ADDICAD: AN INNOVATIVE DIAGNOSTIC TEST FOR TUBERCULOSIS THAT ADDS TO CAD

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €276ktheir share
  • ComBac-AfricaPartner

    Combating Multidrug-Resistant Gram-Negative Bacteria in Africa through Diagnostic and Antimicrobial Stewardship

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €513ktheir share
  • PROTECTPartner

    PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa (PROTECT)

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €225ktheir share
  • WORMVACS2.0Partner

    Innovations for vaccines against helminth infections

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €473ktheir share
  • Vax2MucPartner

    NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €410ktheir share
  • GenPath AfricaPartner

    GENOMIC SURVEILLANCE TO CONTROL PATHOGEN INFECTIONS IN AFRICA

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €495ktheir share
  • MARC SE-AfricaPartner

    Mitigating Antimalarial Resistance Consortium in South-East Africa

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €356ktheir share
  • ESPACEPartner

    Human Cell Atlas of the Pancreas

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €186ktheir share
  • EUCANCanPartner

    EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine.

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €296ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • antibiotic resistance
  • bacteriology
  • biosensors
  • diabetes
  • drug resistance
  • epidemiology
  • epigenetics
  • genomes
  • laboratory samples analysis
  • malaria
  • mortality
  • multidrug resistance
  • mutation

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime